Soy protein β-conglycinin ameliorates pressure overload-induced heart failure by increasing short-chain fatty acid (SCFA)-producing gut microbiota and intestinal SCFAs
Clinical Nutrition · 2024
DOI: 10.1016/j.clnu.2024.09.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nutrition, 2024. Verfasst von Nozomi Furukawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan; Division of Neurogenetics, Center…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Soybean Proteins, Fatty Acids, Volatile, Globulins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND AND AIMS: Soybeans and their ingredients have antioxidant and anti-inflammatory effects on cardiovascular diseases. β-Conglycinin (β-CG), a major constituent of soy proteins, is protective against obesity, hypertension, and chronic kidney disease, but its effects on heart failure remain to be elucidated. We tested the effects of β-CG on left ventricular (LV) remodeling in pressure overload-induced heart failure. METHODS: A transverse aortic constriction (TAC)-induced pressure overload was applied to the heart in 7-week-old C57BL6 male mice that were treated with β-CG, GlcNAc, or sodium propionate. Gut microbiota was analyzed by 16S rRNA sequencing. Fecal short-chain fatty acids (SCFAs) were quantified by GC-MS. The effects of oral antibiotics were examined in β-CG-fed mice. RESULTS: β-CG ameliorated impaired cardiac contractions, cardiac hypertrophy, and myocardial fibrosis in TAC-operated mice. As β-CG is a highly glycosylated protein, we examined the effects of GlcNAc. GlcNAc had similar but less efficient effects on LV remodeling compared to β-CG. β-CG increased three major SCFA-producing intestinal bacteria, as well as fecal concentrations of SCFAs, in sham- and TAC-operated mice. Oral administration of antibiotics nullified the effects of β-CG in TAC-operated mice by markedly reducing SCFA-producing intestinal bacteria and fecal SCFAs. In contrast, oral administration of sodium propionate, one of SCFAs, ameliorated LV remodeling in TAC-operated mice to a similar extent as β-CG. CONCLUSIONS: β-CG was protective against TAC-induced LV remodeling, which was likely to be mediated by increased SCFA-producing gut microbiota and increased intestinal SCFAs. Modified β-CG and/or derivatives arising from β-CG are expected to be developed as prophylactic and/or therapeutic agents to ameliorate devastating symptoms in heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan; Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate Scho…
- Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan.
- Department of Molecular Medicine and Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan; Center for One Medicine Innovative Translational Research (COMIT), Institute for Adva…
Zitieren
APA
Furukawa, N., Kobayashi, M., Ito, M., Matsui, H., Ohashi, K., Murohara, T., Takeda, J. I., Ueyama, J., Hirayama, M., & Ohno, K. (2024). Soy protein β-conglycinin ameliorates pressure overload-induced heart failure by increasing short-chain fatty acid (SCFA)-producing gut microbiota and intestinal SCFAs. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2024.09.045
Vancouver
Furukawa N, Kobayashi M, Ito M, Matsui H, Ohashi K, Murohara T, et al. Soy protein β-conglycinin ameliorates pressure overload-induced heart failure by increasing short-chain fatty acid (SCFA)-producing gut microbiota and intestinal SCFAs. Clinical Nutrition. 2024. doi:10.1016/j.clnu.2024.09.045
BibTeX
@article{Furukawa2024,
author = {Furukawa, Nozomi and Kobayashi, Miku and Ito, Mikako and Matsui, Hiroki and Ohashi, Koji and Murohara, Toyoaki and Takeda, Jun-Ichi and Ueyama, Jun and Hirayama, Masaaki and Ohno, Kinji},
title = {Soy protein β-conglycinin ameliorates pressure overload-induced heart failure by increasing short-chain fatty acid (SCFA)-producing gut microbiota and intestinal SCFAs},
journal = {Clinical Nutrition},
year = {2024},
doi = {10.1016/j.clnu.2024.09.045}
}
EUVIMED